BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND PRDM1, BLIMP1, 639, ENSG00000057657, MGC118925, PRDI-BF1, MGC118924, MGC118922, RP1-134E15_1, O75626, MGC118923 AND Treatment
37984 results:

  • 1. Clinical inertia in thyrotropin suppressive therapy for low-risk differentiated thyroid cancer: A real-world experience at an endocrine center in Bangkok.
    Thewjitcharoen Y; Chatchomchuan W; Wanothayaroj E; Butadej S; Nakasatien S; Krittiyawong S; Rajatanavin R; Himathongkam T
    Medicine (Baltimore); 2024 May; 103(21):e38290. PubMed ID: 38788029
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Predictive role of Naples prognostic score for survival in esophageal cancer: A meta-analysis.
    Guo H; Wang T
    Medicine (Baltimore); 2024 May; 103(21):e38160. PubMed ID: 38787991
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. PPARγ Antagonists Exhibit Antitumor Effects by Regulating Ferroptosis and Disulfidptosis.
    Zhang S; Wang Y; Gu J; Yang Y; Liang J; Wang Y; Ji N; Liu M; Zhang Y; Sun S; Chen Q; Li J
    Biomolecules; 2024 May; 14(5):. PubMed ID: 38786003
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Accelerated Fractionated Radiation Therapy for Localized Glottic Carcinoma.
    Mizukami T; Yamagishi K; Tobikawa M; Nakazato A; Abe H; Morita Y; Saitoh JI
    Curr Oncol; 2024 May; 31(5):2636-2643. PubMed ID: 38785479
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Efficacy and safety of eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with anthracycline/taxanes.
    Chen L; Yan X; Luo T; Tian T; He P; Zhong X
    Cancer Med; 2024 May; 13(10):e7295. PubMed ID: 38785215
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Systematic evaluation and meta-analysis of the prognosis of down-staging human papillomavirus (HPV) positive oropharyngeal squamous cell carcinoma using cetuximab combined with radiotherapy instead of cisplatin combined with radiotherapy.
    Hu Q; Li F; Yang K
    PeerJ; 2024; 12():e17391. PubMed ID: 38784388
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Enhancing oral squamous cell carcinoma detection: a novel approach using improved EfficientNet architecture.
    Soni A; Sethy PK; Dewangan AK; Nanthaamornphong A; Behera SK; Devi B
    BMC Oral Health; 2024 May; 24(1):601. PubMed ID: 38783295
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Feasibility analysis of the application of programmed process endoscopic lateral neck dissection via chest-breast approach in papillary thyroid carcinoma surgery].
    Xu N; Li ZY; Luo XP; Gao HY; Huang JF; Wang YY; Liu XJ; Xu B
    Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1831-1836. PubMed ID: 38782751
    [No Abstract]    [Full Text] [Related]  

  • 9. Comparison of neoadjuvant chemotherapy or chemoradiotherapy plus immunotherapy for locally resectable esophageal squamous cell carcinoma.
    Yang G; Yue H; Zhang X; Zeng C; Tan L; Zhang X
    Front Immunol; 2024; 15():1336798. PubMed ID: 38779667
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A Combination of Curcumin and
    Udompatanakorn C; Ratthawongjirakul P
    J Evid Based Integr Med; 2024; 29():2515690X241258369. PubMed ID: 38778767
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Premature mortality for patients after completely resected early adenocarcinoma of the esophagus or stomach.
    Bollschweiler E; Hölscher AH; Markar SR; Alakus H; Drebber U; Mönig SP; Plum PS
    Cancer Med; 2024 May; 13(10):e7223. PubMed ID: 38778711
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Local intralesional talimogene laherparepvec therapy with complete local response in oral palatine mucosal melanoma: a case report.
    Chitnis SD; Seim NB; Kendra K
    J Med Case Rep; 2024 May; 18(1):257. PubMed ID: 38778387
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Synergistic effects of Ω-3 polyunsaturated fatty acid supplementation and programmed cell death protein 1 blockade on tumor growth and immune modulation in a xenograft model of esophageal cancer.
    Xiao X; Luo S; Huang J; Wan B; Bi N; Wang J
    Clin Nutr ESPEN; 2024 Jun; 61():308-315. PubMed ID: 38777449
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Comparison of Acute Toxicities, Overall treatment Time and Quality of Life in head and neck cancer Patients Treated with IMRT and Helical Tomotherapy.
    R YB; Swamy K; Swaroopa C; Maiya V
    Gulf J Oncolog; 2024 May; 1(45):7-14. PubMed ID: 38774928
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prophylactic central lymph node dissection in cN0 papillary thyroid cancer: a comparative study of via breast and transoral approach versus via breast approach alone.
    Qiu R; Fu J
    Front Endocrinol (Lausanne); 2024; 15():1356739. PubMed ID: 38774230
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Assessing the Impact of Charged Particle Radiation Therapy for head and neck Adenoid Cystic Carcinoma: A Systematic Review and Meta-Analysis.
    Tan M; Chen Y; Du T; Wang Q; Wu X; Zhang Q; Luo H; Liu Z; Sun S; Yang K; Tian J; Wang X
    Technol Cancer Res Treat; 2024; 23():15330338241246653. PubMed ID: 38773763
    [No Abstract]    [Full Text] [Related]  

  • 17. Thyroid papillary carcinoma combined with primary follicular lymphoma: a case report.
    Xu T; Wu L; Ye H; Luo S; Wang J
    Diagn Pathol; 2024 May; 19(1):69. PubMed ID: 38773600
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Surgical outcomes of robotic thyroidectomy for thyroid tumors over 4 cm via the bilateral axillo-breast approach.
    Bae HL; Wong JS; Kim SJ; Jung Y; Choi JB; Kwak J; Yu HW; Chai YJ; Choi JY; Lee KE
    Sci Rep; 2024 May; 14(1):11646. PubMed ID: 38773181
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. State-of-the-Art Advancements in Gastroesophageal cancer treatment: Harnessing Biomarkers for Precision Care.
    Balmaceda NB; Petrillo A; Krishnan M; Zhao JJ; Kim S; Klute KA; Sundar R
    Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e431060. PubMed ID: 38771996
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Comparing the clinical outcomes of initial surgery and primary definitive radiotherapy with a dosage of 6600 cGy or higher in cT1-2N0M0 oral cavity squamous cell carcinoma: A nationwide cohort study.
    Lin CY; Chen WC; Wen YW; Fan KH; Lin JC; Ng SH; Tsai YT; Lee SR; Kang CJ; Lee LY; Chien CY; Hua CH; Wang CP; Chen TM; Terng SD; Tsai CY; Wang HM; Hsieh CH; Yeh CH; Lin CH; Tsao CK; Cheng NM; Fang TJ; Huang SF; Lee LA; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Liao CT
    Cancer Med; 2024 May; 13(10):e7127. PubMed ID: 38770540
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 1900.